These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 33692796)

  • 21. Review: dendritic cell immunotherapy for melanoma.
    Hadzantonis M; O'Neill H
    Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.
    Dillman RO; Selvan SR; Schiltz PM; McClay EF; Barth NM; DePriest C; de Leon C; Mayorga C; Cornforth AN; Allen K
    Cancer Biother Radiopharm; 2009 Jun; 24(3):311-9. PubMed ID: 19538053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
    Grover A; Kim GJ; Lizée G; Tschoi M; Wang G; Wunderlich JR; Rosenberg SA; Hwang ST; Hwu P
    Clin Cancer Res; 2006 Oct; 12(19):5801-8. PubMed ID: 17020987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
    Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
    Dillman RO; Cornforth AN; Depriest C; McClay EF; Amatruda TT; de Leon C; Ellis RE; Mayorga C; Carbonell D; Cubellis JM
    J Immunother; 2012 Oct; 35(8):641-9. PubMed ID: 22996370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
    Saberian C; Amaria RN; Najjar AM; Radvanyi LG; Haymaker CL; Forget MA; Bassett RL; Faria SC; Glitza IC; Alvarez E; Parshottam S; Prieto V; Lizée G; Wong MK; McQuade JL; Diab A; Yee C; Tawbi HA; Patel S; Shpall EJ; Davies MA; Hwu P; Bernatchez C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cells in melanoma immunotherapy.
    Faries MB; Czerniecki BJ
    Curr Treat Options Oncol; 2005 May; 6(3):175-84. PubMed ID: 15869729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies.
    Pyzer AR; Avigan DE; Rosenblatt J
    Hum Vaccin Immunother; 2014; 10(11):3125-31. PubMed ID: 25625926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New approaches to the development of adenoviral dendritic cell vaccines in melanoma.
    Butterfield LH; Vujanovic L
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1399-408. PubMed ID: 21154122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic-cell vaccination for metastatic melanoma?
    Chen V
    Lancet Oncol; 2006 May; 7(5):368. PubMed ID: 16696162
    [No Abstract]   [Full Text] [Related]  

  • 32. Dendritic cell vaccination as a treatment modality for melanoma.
    Eubel J; Enk AH
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1631-42. PubMed ID: 19895246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD141
    Lee YS; O'Brien LJ; Walpole CM; Pearson FE; Leal-Rojas IM; Masterman KA; Atkinson V; Barbour A; Radford KJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to reverse melanoma-induced T-cell dysfunction.
    Fourcade J; Zarour HM
    Clin Dermatol; 2013; 31(3):251-6. PubMed ID: 23608444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
    Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
    J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Anti-melanoma Efficacy of a Pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells.
    Liu J; Hu Y; Guo Q; Yu X; Shao L; Zhang C
    Front Immunol; 2019; 10():2721. PubMed ID: 31849942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell vaccination and immune monitoring.
    Aarntzen EH; Figdor CG; Adema GJ; Punt CJ; de Vries IJ
    Cancer Immunol Immunother; 2008 Oct; 57(10):1559-68. PubMed ID: 18618110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
    Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
    J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model.
    Bose A; Lowe DB; Rao A; Storkus WJ
    Melanoma Res; 2012 Jun; 22(3):236-43. PubMed ID: 22504156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs and dendritic cell-based vaccination in melanoma patients.
    de Rosa F; Fanini F; Guidoboni M; Vannini I; Amadori D; Ridolfi R; Ridolfi L; Fabbri M
    Melanoma Res; 2014 Jun; 24(3):181-9. PubMed ID: 24638153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.